☰

David Burn - Publications

Affiliations: 
Neuroscience Newcastle University, UK 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

268 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Gerakios F, Yarnall AJ, Bate G, Wright L, Davis D, Stephan BCM, Robinson L, Brayne C, Stebbins G, Taylor JP, Burn DJ, Allan LM, Richardson SJ, Lawson RA. Delirium is more common and associated with worse outcomes in Parkinson's disease compared to older adult controls: results of two prospective longitudinal cohort studies. Age and Ageing. 53. PMID 38497236 DOI: 10.1093/ageing/afae046  0.338
2023 Cardoso F, Goetz CG, Mestre TA, Sampaio C, Adler CH, Berg D, Bloem BR, Burn DJ, Fitts MS, Gasser T, Klein C, de Tijssen MAJ, Lang AE, Lim SY, Litvan I, et al. A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 38093469 DOI: 10.1002/mds.29683  0.301
2022 Cullinan RJ, Richardson SJ, Yarnall AJ, Burn DJ, Allan LM, Lawson RA. Documentation and Diagnosis of Delirium in Parkinson's Disease. Acta Psychiatrica Scandinavica. PMID 35771186 DOI: 10.1111/acps.13470  0.405
2022 Lawton M, Tan MM, Ben-Shlomo Y, Baig F, Barber T, Klein JC, Evetts SG, Millin S, Malek N, Grosset K, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, et al. Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 35732412 DOI: 10.1136/jnnp-2021-327376  0.393
2022 Boel JA, de Bie RMA, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ. Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia. Movement Disorders Clinical Practice. 9: 479-483. PMID 35582313 DOI: 10.1002/mdc3.13451  0.382
2022 Sigurdsson HP, Yarnall AJ, Galna B, Lord S, Alcock L, Lawson RA, Colloby SJ, Firbank MJ, Taylor JP, Pavese N, Brooks DJ, O'Brien JT, Burn DJ, Rochester L. Gait-Related Metabolic Covariance Networks at Rest in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 35285068 DOI: 10.1002/mds.28977  0.403
2022 Xing Y, Sapuan AH, Martín-Bastida A, Naidu S, Tench C, Evans J, Sare G, Schwarz ST, Al-Bachari S, Parkes LM, Kanavou S, Raw J, Silverdale M, Bajaj N, Pavese N, ... Burn D, et al. Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 35165920 DOI: 10.1002/mds.28934  0.34
2021 Lawson RA, Williams-Gray CH, Camacho M, Duncan GW, Khoo TK, Breen DP, Barker RA, Rochester L, Burn DJ, Yarnall AJ. Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort. Journal of Parkinson's Disease. PMID 34024781 DOI: 10.3233/JPD-212581  0.426
2020 Wilson J, Yarnall AJ, Craig CE, Galna B, Lord S, Morris R, Lawson RA, Alcock L, Duncan GW, Khoo TK, O'Brien JT, Burn DJ, Taylor JP, Ray NJ, Rochester L. Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33382126 DOI: 10.1002/mds.28453  0.404
2020 Wilson J, Alcock L, Yarnall AJ, Lord S, Lawson RA, Morris R, Taylor JP, Burn DJ, Rochester L, Galna B. Gait Progression Over 6 Years in Parkinson's Disease: Effects of Age, Medication, and Pathology. Frontiers in Aging Neuroscience. 12: 577435. PMID 33192470 DOI: 10.3389/fnagi.2020.577435  0.384
2020 Tan MMX, Lawton MA, Jabbari E, Reynolds RH, Iwaki H, Blauwendraat C, Kanavou S, Pollard MI, Hubbard L, Malek N, Grosset KA, Marrinan SL, Bajaj N, Barker RA, Burn DJ, et al. Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33111402 DOI: 10.1002/mds.28342  0.37
2020 O'Brien JT, McKeith IG, Thomas AJ, Bamford C, Vale L, Hill S, Allan L, Finch T, McNally R, Hayes L, Surendranathan A, Kane JPM, Dunn S, Bentley A, Barker S, ... ... Burn D, et al. Introduction of a Management Toolkit for Lewy Body Dementia: A Pilot Cluster-Randomized Trial. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32960456 DOI: 10.1002/Mds.28282  0.375
2020 Surendranathan A, Kane JPM, Bentley A, Barker SAH, Taylor JP, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG, Burn DJ, O'Brien JT. Clinical diagnosis of Lewy body dementia. Bjpsych Open. 6: e61. PMID 32539875 DOI: 10.1192/bjo.2020.44  0.3
2020 Gratwicke J, Zrinzo L, Kahan J, Peters A, Brechany U, McNichol A, Beigi M, Akram H, Hyam J, Oswal A, Day B, Mancini L, Thornton J, Yousry T, Crutch SJ, ... ... Burn D, et al. Bilateral Nucleus Basalis of Meynert Deep Brain Stimulation for dementia with Lewy bodies A Randomised Clinical Trial. Brain Stimulation. PMID 32334074 DOI: 10.1016/J.Brs.2020.04.010  0.319
2020 Dlay JK, Duncan GW, Khoo TK, Williams-Gray CH, Breen DP, Barker RA, Burn DJ, Lawson RA, Yarnall AJ. Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson's Disease Cohort (ICICLE-PD). Brain Sciences. 10. PMID 32024222 DOI: 10.3390/Brainsci10020078  0.465
2020 Lawson RA, Richardson SJ, Yarnall AJ, Burn DJ, Allan LM. Identifying delirium in Parkinson disease: A pilot study. International Journal of Geriatric Psychiatry. PMID 31994774 DOI: 10.1002/gps.5270  0.369
2019 Martin-Ruiz C, Williams-Gray CH, Yarnall AJ, Boucher JJ, Lawson RA, Wijeyekoon RS, Barker RA, Kolenda C, Parker C, Burn DJ, Von Zglinicki T, Saretzki G. Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson's Disease: The ICICLE-PD Study. Journal of Parkinson's Disease. PMID 31868677 DOI: 10.3233/JPD-191724  0.412
2019 Jabbari E, Holland N, Chelban V, Jones PS, Lamb R, Rawlinson C, Guo T, Costantini AA, Tan MMX, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, ... ... Burn DJ, et al. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. Jama Neurology. PMID 31860007 DOI: 10.1001/Jamaneurol.2019.4347  0.317
2019 Ahamadi M, Conrado DJ, Macha S, Sinha V, Stone J, Burton J, Nicholas T, Gallagher J, Dexter D, Bani M, Boroojerdi B, Smit H, Weidemann J, Chen C, Yang M, ... ... Burn D, et al. Development of a disease progression model for leucine-rich repeat kinase 2 in Parkinson's disease to inform clinical trial designs. Clinical Pharmacology and Therapeutics. PMID 31544231 DOI: 10.1002/Cpt.1634  0.468
2019 Taylor JP, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, Allan LM, Thomas AJ, O'Brien JT. New evidence on the management of Lewy body dementia. The Lancet. Neurology. PMID 31519472 DOI: 10.1016/S1474-4422(19)30153-X  0.313
2019 Stuart S, Lawson RA, Yarnall AJ, Nell J, Alcock L, Duncan GW, Khoo TK, Barker RA, Rochester L, Burn DJ. Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31442355 DOI: 10.1002/Mds.27813  0.387
2019 Wiblin L, Durcan R, Galna B, Lee M, Burn D. Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study. Journal of Movement Disorders. 12: 177-183. PMID 31390854 DOI: 10.14802/Jmd.19015  0.367
2019 Malek N, Kanavou S, Lawton MA, Pitz V, Grosset KA, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Williams NM, Wood N, Morris HR, Grosset DG, et al. L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression. Parkinsonism & Related Disorders. PMID 31105012 DOI: 10.1016/J.Parkreldis.2019.05.022  0.355
2019 Pasquini J, Durcan R, Wiblin L, Gersel Stokholm M, Rochester L, Brooks DJ, Burn D, Pavese N. Clinical implications of early caudate dysfunction in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31079063 DOI: 10.1136/Jnnp-2018-320157  0.509
2019 King E, O'Brien J, Donaghy P, Williams-Gray CH, Lawson RA, Morris CM, Barnett N, Olsen K, Martin-Ruiz C, Burn D, Yarnall AJ, Taylor JP, Duncan G, Khoo TK, Thomas A. Inflammation in Mild Cognitive Impairment due to Parkinson's disease, Lewy Body disease and Alzheimer's disease. International Journal of Geriatric Psychiatry. PMID 30993722 DOI: 10.1002/Gps.5124  0.484
2019 Sleeman I, Lawson RA, Yarnall AJ, Duncan GW, Johnston F, Khoo TK, Burn DJ. Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease. Journal of Parkinson's Disease. PMID 30909247 DOI: 10.3233/JPD-181535  0.323
2019 Durcan R, Wiblin L, Lawson RA, Khoo TK, Yarnall AJ, Duncan GW, Brooks DJ, Pavese N, Burn DJ. Prevalence and duration of non-motor symptoms in prodromal Parkinson's Disease. European Journal of Neurology. PMID 30706593 DOI: 10.1111/Ene.13919  0.357
2019 Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I. Dementia with Lewy bodies: an update and outlook. Molecular Neurodegeneration. 14: 5. PMID 30665447 DOI: 10.1186/S13024-019-0306-8  0.529
2019 Hoogland J, Boel JA, de Bie RMA, Schmand BA, Geskus RB, Dalrymple-Alford JC, Marras C, Adler CH, Weintraub D, Junque C, Pedersen KF, Mollenhauer B, Goldman JG, Tröster AI, Burn DJ, et al. Risk of Parkinson's disease dementia related to level I MDS PD-MCI. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30653248 DOI: 10.1002/Mds.27617  0.397
2018 Lawton M, Ben-Shlomo Y, May MT, Baig F, Barber TR, Klein JC, Swallow DMA, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, et al. Developing and validating Parkinson's disease subtypes and their motor and cognitive progression. Journal of Neurology, Neurosurgery, and Psychiatry. 89: 1279-1287. PMID 30464029 DOI: 10.1136/Jnnp-2018-318337  0.427
2018 Lawson RA, McDonald C, Burn DJ. Defining delirium in idiopathic Parkinson's disease: A systematic review. Parkinsonism & Related Disorders. PMID 30279060 DOI: 10.1016/j.parkreldis.2018.09.025  0.345
2018 Gravell R, Duncan GW, Khoo TK, Burn DJ, Sayer AA, Barker RA, Lawson RA, Yarnall AJ. Multimorbidity Predicts Quality of Life but not Motor Severity in Early Parkinson's Disease. Journal of Parkinson's Disease. PMID 30248064 DOI: 10.3233/JPD-181428  0.364
2018 Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, ... ... Burn DJ, et al. Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30216541 DOI: 10.1002/Mds.110  0.315
2018 Chahine LM, Urbe L, Caspell-Garcia C, Aarsland D, Alcalay R, Barone P, Burn D, Espay AJ, Hamilton JL, Hawkins KA, Lasch S, Leverenz JB, Litvan I, Richard I, Siderowf A, et al. Cognition among individuals along a spectrum of increased risk for Parkinson's disease. Plos One. 13: e0201964. PMID 30125297 DOI: 10.1371/Journal.Pone.0201964  0.47
2018 Thomas AJ, Taylor JP, McKeith I, Bamford C, Burn D, Allan L, O'Brien J. Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study. International Journal of Geriatric Psychiatry. PMID 30091150 DOI: 10.1002/Gps.4948  0.34
2018 Clegg BJ, Duncan GW, Khoo TK, Barker RA, Burn DJ, Yarnall AJ, Lawson RA. Categorising Visual Hallucinations in Early Parkinson's Disease. Journal of Parkinson's Disease. PMID 30040741 DOI: 10.3233/JPD-181338  0.377
2018 Lawson RA, Collerton D, Taylor JP, Burn DJ, Brittain KR. Coping with Cognitive Impairment in People with Parkinson's Disease and Their Carers: A Qualitative Study. Parkinson's Disease. 2018: 1362053. PMID 29850013 DOI: 10.1155/2018/1362053  0.348
2018 Minett T, Su L, Mak E, Williams G, Firbank M, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O'Brien JT. Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study. Journal of Neurology. PMID 29696499 DOI: 10.1007/S00415-018-8873-0  0.465
2018 Malek N, Weil RS, Bresner C, Lawton MA, Grosset KA, Tan M, Bajaj N, Barker RA, Burn DJ, Foltynie T, Hardy J, Wood NW, Ben-Shlomo Y, Williams NW, Grosset DG, et al. Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29378790 DOI: 10.1136/Jnnp-2017-317348  0.401
2017 Malek N, Lawton MA, Grosset KA, Bajaj N, Barker RA, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Ben-Shlomo Y, Wood NW, Grosset DG. Autonomic Dysfunction in Early Parkinson's Disease: Results from the United Kingdom Tracking Parkinson's Study. Movement Disorders Clinical Practice. 4: 509-516. PMID 30363477 DOI: 10.1002/Mdc3.12454  0.409
2017 Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Galtrey C, Guzman NV, Hellman B, James B, Pal S, Stamford J, Steiger M, Stott RW, Teo J, Barker RA, Wang E, et al. Erratum: Author Correction: Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease. Npj Parkinson's Disease. 3: 32. PMID 29152558 DOI: 10.1038/S41531-017-0034-0  0.338
2017 Sleeman I, Aspray T, Lawson R, Coleman S, Duncan G, Khoo TK, Schoenmakers I, Rochester L, Burn D, Yarnall A. The Role of Vitamin D in Disease Progression in Early Parkinson's Disease. Journal of Parkinson's Disease. PMID 28984616 DOI: 10.3233/Jpd-171122  0.43
2017 Lord S, Galna B, Yarnall AJ, Morris R, Coleman S, Burn D, Rochester L. Natural history of falls in an incident cohort of Parkinson's disease: early evolution, risk and protective features. Journal of Neurology. PMID 28948348 DOI: 10.1007/S00415-017-8620-Y  0.472
2017 Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, et al. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 32: 1264-1310. PMID 28887905 DOI: 10.1002/Mds.27115  0.455
2017 Thomas AJ, Attems J, Colloby SJ, O'Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z. Author response: Autopsy validation of (123)I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology. 89: 751. PMID 28808169 DOI: 10.1212/Wnl.0000000000004254  0.468
2017 Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Galtrey C, Guzman NV, Hellman B, Ben James, Pal S, Stamford J, Steiger M, Stott RW, Teo J, Barker RA, Wang E, et al. Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease. Npj Parkinson's Disease. 3: 2. PMID 28649602 DOI: 10.1038/S41531-016-0003-Z  0.431
2017 Miller N, Nath U, Noble E, Burn D. Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson's disease, PSP and MSA-P. Neurodegenerative Disease Management. PMID 28632098 DOI: 10.2217/Nmt-2017-0005  0.486
2017 Hoogland J, Boel JA, de Bie RMA, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ. Mild cognitive impairment as a risk factor for Parkinson's disease dementia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28605056 DOI: 10.1002/Mds.27002  0.37
2017 McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, ... ... Burn D, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. PMID 28592453 DOI: 10.1212/Wnl.0000000000004058  0.396
2017 Caspell-Garcia C, Simuni T, Tosun-Turgut D, Wu IW, Zhang Y, Nalls M, Singleton A, Shaw LA, Kang JH, Trojanowski JQ, Siderowf A, Coffey C, Lasch S, Aarsland D, Burn D, et al. Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease. Plos One. 12: e0175674. PMID 28520803 DOI: 10.1371/Journal.Pone.0175674  0.485
2017 Morris R, Lord S, Lawson RA, Coleman S, Galna B, Duncan GW, Khoo TK, Yarnall AJ, Burn DJ, Rochester L. Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson's Disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 28472409 DOI: 10.1093/gerona/glx071  0.372
2017 Malek N, Lawton MA, Grosset KA, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, Wood N, Grosset DG. Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases. Parkinsonism & Related Disorders. PMID 28431829 DOI: 10.1016/J.Parkreldis.2017.04.006  0.361
2017 Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Mollenhauer B, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT. Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease. Neurobiology of Aging. 55: 78-90. PMID 28431288 DOI: 10.1016/J.Neurobiolaging.2017.03.012  0.379
2017 Lord S, Galna B, Yarnall AJ, Coleman S, Burn D, Rochester L. Have we been overestimating fall rates in Parkinson's disease? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28429864 DOI: 10.1002/Mds.27009  0.431
2017 Burté F, Houghton D, Lowes H, Pyle A, Nesbitt S, Yarnall A, Yu-Wai-Man P, Burn DJ, Santibanez-Koref M, Hudson G. metabolic profiling of Parkinson's disease and mild cognitive impairment. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28394042 DOI: 10.1002/mds.26992  0.339
2017 Wiblin L, Lee M, Burn D. Palliative care and its emerging role in Multiple System Atrophy and Progressive Supranuclear Palsy. Parkinsonism & Related Disorders. 34: 7-14. PMID 28341224 DOI: 10.1016/J.Parkreldis.2016.10.013  0.391
2017 Rochester L, Galna B, Lord S, Yarnall AJ, Morris R, Duncan G, Khoo TK, Mollenhauer B, Burn DJ. Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease. Neurology. PMID 28330963 DOI: 10.1212/WNL.0000000000003840  0.362
2017 Firbank MJ, Yarnall AJ, Lawson RA, Duncan GW, Khoo TK, Petrides GS, O'Brien JT, Barker RA, Maxwell RJ, Brooks DJ, Burn DJ. Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study. Journal of Neurology, Neurosurgery, and Psychiatry. 88: 310-316. PMID 28315844 DOI: 10.1136/Jnnp-2016-313918  0.317
2017 Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, Barker RA, Burn DJ. Stability of mild cognitive impairment in newly diagnosed Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28250029 DOI: 10.1136/jnnp-2016-315099  0.426
2017 Dissanayaka NN, Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Barker RA, Burn DJ. Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease. Parkinsonism & Related Disorders. PMID 28108263 DOI: 10.1016/j.parkreldis.2017.01.001  0.374
2017 Peraza LR, Nesbitt D, Lawson RA, Duncan GW, Yarnall AJ, Khoo TK, Kaiser M, Firbank MJ, O'Brien JT, Barker RA, Brooks DJ, Burn DJ, Taylor JP. Intra- and inter-network functional alterations in Parkinson's disease with mild cognitive impairment. Human Brain Mapping. PMID 28084651 DOI: 10.1002/Hbm.23499  0.337
2017 Wiblin L, Durcan R, Galna B, Pavese N, Burn D. 170Subjective Onset of Symptoms Relative to Diagnosis in Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) Age and Ageing. 46. DOI: 10.1093/Ageing/Afx144.174  0.303
2017 Thomas A, Attems J, Colloby SJ, O'Brien JT, McKeith IG, Walker R, Lee L, Burn D, Lett D, Walker Z. Validation By Neuropathology Of Fp-Cit Neuroimaging In Dementia With Lewy Bodies Alzheimers & Dementia. 13: 1462. DOI: 10.1016/J.Jalz.2017.07.530  0.335
2017 Bamford C, Boyles M, Finch T, Allan LM, Burn D, McKeith IG, Taylor J, Thomas A, O'Brien JT. “What Difference Does It Make?” Clinician Views On Diagnosing Lewy Body Dementia Alzheimers & Dementia. 13: 737. DOI: 10.1016/J.Jalz.2017.06.966  0.338
2017 Woodside J, Lamb R, Jabbari E, Chelban V, Burn D, Church A, Gerhard A, Hu M, Leigh N, Rowe JB, Houlden H, Morris H. The Prospect Study: Development Of A Uk-Based Longitudinal Observational Study Of Psp, Cbd, Msa And Atypical Parkinsonism Syndromes Alzheimers & Dementia. 13: 348. DOI: 10.1016/J.Jalz.2017.06.274  0.346
2017 Minett T, Su L, Mak E, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O'Brien JT. [IC-P-074]: LONGITUDINAL DIFFUSION TENSOR IMAGING AS A PREDICTOR OF COGNITIVE DOMAINS DECLINE IN EARLY STAGE PARKINSON's DISEASE: ICICLE-PD STUDY Alzheimer's & Dementia. 13: P61-P61. DOI: 10.1016/j.jalz.2017.06.2347  0.331
2017 Minett T, Su L, Mak E, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O'Brien JT. Longitudinal Diffusion Tensor Imaging As A Predictor Of Cognitive Domains Decline In Early Stage Parkinson’S Disease: Icicle-Pd Study Alzheimers & Dementia. 13: 1353. DOI: 10.1016/J.Jalz.2017.06.2088  0.412
2017 Surendranathan A, Kane J, Bentley A, Barker SH, Taylor J, Thomas A, McKeith IG, Burn D, O'Brien JT. Diagnosis Of Dementia In Parkinson’S Disease In Clinical Practice Alzheimers & Dementia. 13: 840. DOI: 10.1016/J.Jalz.2017.06.1178  0.375
2016 Thomas AJ, Attems J, Colloby SJ, O'Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z. Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology. PMID 27940650 DOI: 10.1212/Wnl.0000000000003512  0.339
2016 Thomas AJ, Taylor JP, McKeith I, Bamford C, Burn D, Allan L, O'Brien J. Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study. International Journal of Geriatric Psychiatry. PMID 27928840 DOI: 10.1002/Gps.4609  0.405
2016 McDonald C, Winge K, Burn DJ. Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management. Parkinsonism & Related Disorders. PMID 27865667 DOI: 10.1016/j.parkreldis.2016.10.024  0.37
2016 Pyle A, Lowes H, Brennan R, Kurzawa-Akanbi M, Yarnall A, Burn D, Hudson G. Reduced mitochondrial DNA is not a biomarker of depression in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27753152 DOI: 10.1002/Mds.26825  0.343
2016 Swallow DM, Lawton MA, Grosset KA, Malek N, Klein J, Baig F, Ruffmann C, Bajaj NP, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Morris HR, Williams N, Wood NW, et al. Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27671901 DOI: 10.1136/jnnp-2016-313642  0.392
2016 Lord S, Galna B, Yarnall AJ, Coleman S, Burn D, Rochester L. Predicting first fall in newly diagnosed Parkinson's disease: Insights from a fall-naïve cohort. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27621153 DOI: 10.1002/Mds.26742  0.43
2016 Heinzel S, Roeben B, Ben-Shlomo Y, Lerche S, Alves G, Barone P, Behnke S, Berendse HW, Bloem BR, Burn D, Dodel R, Grosset DG, Hu M, Kasten M, Krüger R, et al. Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned. Frontiers in Aging Neuroscience. 8: 147. PMID 27445791 DOI: 10.3389/Fnagi.2016.00147  0.478
2016 Malek N, Lawton MA, Swallow DM, Grosset KA, Marrinan SL, Bajaj N, Barker RA, Burn DJ, Hardy J, Morris HR, Williams NM, Wood N, Ben-Shlomo Y, Grosset DG. Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27324570 DOI: 10.1002/Mds.26698  0.344
2016 Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, et al. Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Frontiers in Aging Neuroscience. 8: 121. PMID 27303289 DOI: 10.3389/Fnagi.2016.00121  0.5
2016 Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, Barker RA, Collerton D, Taylor JP, Burn DJ. Cognitive decline and quality of life in incident Parkinson's disease: The role of attention. Parkinsonism & Related Disorders. PMID 27094482 DOI: 10.1016/j.parkreldis.2016.04.009  0.315
2016 McDonald C, Newton JL, Burn DJ. Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27091624 DOI: 10.1002/mds.26632  0.369
2016 Swallow DM, Lawton MA, Grosset KA, Malek N, Smith CR, Bajaj NP, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams N, Wood NW, Grosset DG, et al. Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection. Journal of Parkinson's Disease. PMID 27003780 DOI: 10.3233/Jpd-150741  0.384
2016 Williams-Gray CH, Wijeyekoon R, Yarnall AJ, Lawson RA, Breen DP, Evans JR, Cummins GA, Duncan GW, Khoo TK, Burn DJ, Barker RA. Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD). Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26999434 DOI: 10.1002/mds.26563  0.374
2016 Breen DP, Nombela C, Vuono R, Jones PS, Fisher K, Burn DJ, Brooks DJ, Reddy AB, Rowe JB, Barker RA. Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26971528 DOI: 10.1002/Mds.26592  0.307
2016 Morris R, Lord S, Bunce J, Burn D, Rochester L. Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease. Neuroscience and Biobehavioral Reviews. 64: 326-45. PMID 26915926 DOI: 10.1016/J.Neubiorev.2016.02.012  0.335
2016 Keogh MJ, Kurzawa-Akanbi M, Griffin H, Douroudis K, Ayers KL, Hussein RI, Hudson G, Pyle A, Cordell HJ, Attems J, McKeith IG, O'Brien JT, Burn DJ, Morris CM, Thomas AJ, et al. Exome sequencing in dementia with Lewy bodies. Translational Psychiatry. 6: e728. PMID 26836416 DOI: 10.1038/Tp.2015.220  0.405
2016 Urwyler P, Nef T, Müri R, Archibald N, Makin SM, Collerton D, Taylor JP, Burn D, McKeith I, Mosimann UP. Visual Hallucinations in Eye Disease and Lewy Body Disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 24: 350-8. PMID 26796926 DOI: 10.1016/J.Jagp.2015.10.007  0.417
2016 Pyle A, Anugrha H, Kurzawa-Akanbi M, Yarnall A, Burn D, Hudson G. Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease. Neurobiology of Aging. 38: 216.e7-10. PMID 26639155 DOI: 10.1016/J.Neurobiolaging.2015.10.033  0.426
2016 Martin-Bastida A, Schwarz S, Xing Y, Pietracupa S, Burn D, Silverdale M, Bajaj N, Grosset D, Auer D, Paola P. Neuromelanin-Sensitive Resonance Imaging As A Parkinson'S Disease Biomarker Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-315106.107  0.461
2016 Mills R, Ballard C, Isaacson S, Williams H, Corbett A, Coate B, Pahwa R, Rascol O, Burn D. Impact of current antipsychotic medications on comparative mortality and adverse events in people with Parkinson’s disease psychosis (PDP) Parkinsonism & Related Disorders. 22. DOI: 10.1016/J.Parkreldis.2015.10.194  0.338
2016 Lakshminarayana R, Wang D, Burn D, Chaudhuri K, Hellman B, SMART-PD Investigators I. Using A Smartphone Based Self-Management Platform To Support Medication Adherence And Clinical Consultation In Parkinson’s Disease Results From The Smart-PD Randomised Controlled Trial Value in Health. 19: A700. DOI: 10.1016/J.Jval.2016.09.2027  0.39
2015 Malek N, Swallow DM, Grosset KA, Lawton MA, Smith CR, Bajaj NP, Barker RA, Ben-Shlomo Y, Bresner C, Burn DJ, Foltynie T, Morris HR, Williams N, Wood NW, Grosset DG, et al. Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients. Acta Neurologica Scandinavica. PMID 26626018 DOI: 10.1111/Ane.12538  0.418
2015 Tang EY, Burn D, Taylor JP, Robinson L. Dementia with Lewy bodies: The emerging role of primary care. The European Journal of General Practice. 1-5. PMID 26605958 DOI: 10.3109/13814788.2015.1101061  0.363
2015 Lerche S, Liepelt-Scarfone I, Alves G, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Burn D, Dodel R, Grosset D, Heinzel S, Hu M, Kasten M, Krüger R, Maetzler W, et al. Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD. Neuroepidemiology. 45: 282-297. PMID 26523894 DOI: 10.1159/000439221  0.476
2015 Malek N, Swallow DM, Grosset KA, Lawton MA, Marrinan SL, Lehn AC, Bresner C, Bajaj N, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Hardy J, Morris HR, Williams NM, et al. Tracking Parkinson's: Study Design and Baseline Patient Data. Journal of Parkinson's Disease. PMID 26485428 DOI: 10.3233/Jpd-150662  0.464
2015 Yarnall AJ, Lawson RA, Duncan GW, Breen DP, Khoo TK, Brooks D, Barker RA, Taylor JP, Burn DJ. Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease? Journal of Parkinson's Disease. PMID 26444094 DOI: 10.3233/Jpd-150664  0.359
2015 Guidi M, Paciaroni L, Paolini S, Scarpino O, Burn DJ. Semantic profiles in mild cognitive impairment associated with Alzheimer's and Parkinson's diseases. Functional Neurology. 30: 113-8. PMID 26415783 DOI: 10.11138/fneur/2015.30.2.113  0.371
2015 Stephenson D, Hu MT, Romero K, Breen K, Burn D, Ben-Shlomo Y, Bhattaram A, Isaac M, Venuto C, Kubota K, Little MA, Friend S, Lovestone S, Morris HR, Grosset D, et al. Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson's Disease1. Journal of Parkinson's Disease. 5: 581-94. PMID 26406139 DOI: 10.3233/Jpd-150570  0.351
2015 Pyle A, Brennan R, Kurzawa-Akanbi M, Yarnall A, Thouin A, Mollenhauer B, Burn D, Chinnery PF, Hudson G. Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early-stage Parkinson's disease. Annals of Neurology. 78: 1000-4. PMID 26343811 DOI: 10.1002/Ana.24515  0.463
2015 Pillas M, Selai C, Quinn NP, Lees A, Litvan I, Lang A, Bower J, Burn D, Low P, Schrag A. Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers). Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 26264781 DOI: 10.1007/S11136-015-1071-Y  0.303
2015 Duncan GW, Firbank MJ, Yarnall AJ, Khoo TK, Brooks DJ, Barker RA, Burn DJ, O'Brien JT. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26202802 DOI: 10.1002/Mds.26312  0.36
2015 Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain : a Journal of Neurology. PMID 26173861 DOI: 10.1093/Brain/Awv211  0.389
2015 Burn D. UK Parkinson's Excellence Network: time for a paradigm shift in Parkinson's care. Neurodegenerative Disease Management. 5: 177-180. PMID 26107315 DOI: 10.2217/Nmt.15.15  0.36
2015 Burn D. UK Parkinson's Excellence Network: empowering service improvement across the UK Neurodegenerative Disease Management. 5: 173-176. PMID 26107314 DOI: 10.2217/Nmt.15.18  0.354
2015 Burn DJ. The treatment of mild cognitive impairment associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 881-2. PMID 26011710 DOI: 10.1002/mds.26245  0.311
2015 Carbutt S, Duff J, Yarnall A, Burn DJ, Hudson G. Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson's disease. Neuroscience Letters. 594: 66-9. PMID 25817358 DOI: 10.1016/j.neulet.2015.03.048  0.332
2015 Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, et al. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 919-27. PMID 25737166 DOI: 10.1002/Mds.26170  0.483
2015 Urwyler P, Nef T, Müri RM, Killen A, Collerton D, Burn D, McKeith I, Mosimann UP. Patient and Informant Views on Visual Hallucinations in Parkinson Disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 23: 970-6. PMID 25623941 DOI: 10.1016/J.Jagp.2014.12.190  0.367
2015 Mactier K, Lord S, Godfrey A, Burn D, Rochester L. The relationship between real world ambulatory activity and falls in incident Parkinson's disease: influence of classification scheme. Parkinsonism & Related Disorders. 21: 236-42. PMID 25572498 DOI: 10.1016/J.Parkreldis.2014.12.014  0.449
2015 Galna B, Lord S, Burn DJ, Rochester L. Progression of gait dysfunction in incident Parkinson's disease: Impact of medication and phenotype Movement Disorders. 30: 359-367. PMID 25546558 DOI: 10.1002/mds.26110  0.386
2014 Lord S, Galna B, Coleman S, Yarnall A, Burn D, Rochester L. Cognition and gait show a selective pattern of association dominated by phenotype in incident Parkinson's disease. Frontiers in Aging Neuroscience. 6: 249. PMID 25374538 DOI: 10.3389/Fnagi.2014.00249  0.454
2014 Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Cummins G, Galtrey C, Hellman B, Pal S, Stamford J, Steiger M, Williams A. Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson's disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014). Trials. 15: 374. PMID 25257518 DOI: 10.1186/1745-6215-15-374  0.425
2014 Nombela C, Rowe JB, Winder-Rhodes SE, Hampshire A, Owen AM, Breen DP, Duncan GW, Khoo TK, Yarnall AJ, Firbank MJ, Chinnery PF, Robbins TW, O'Brien JT, Brooks DJ, Burn DJ, et al. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain : a Journal of Neurology. 137: 2743-58. PMID 25080285 DOI: 10.1093/Brain/Awu201  0.377
2014 Lawson RA, Yarnall AJ, Duncan GW, Khoo TK, Breen DP, Barker RA, Collerton D, Taylor JP, Burn DJ. Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life. Parkinsonism & Related Disorders. 20: 1071-5. PMID 25074728 DOI: 10.1016/j.parkreldis.2014.07.004  0.378
2014 Lawson RA, Yarnall AJ, Duncan GW, Khoo TK, Breen DP, Barker RA, Collerton D, Taylor JP, Burn DJ. Quality of life and mild cognitive impairment in early Parkinson's disease: does subtype matter? Journal of Parkinson's Disease. 4: 331-6. PMID 24919824 DOI: 10.3233/JPD-140390  0.31
2014 Burn D, Weintraub D, Ravina B, Litvan I. Cognition in movement disorders: where can we hope to be in ten years? Movement Disorders : Official Journal of the Movement Disorder Society. 29: 704-11. PMID 24757118 DOI: 10.1002/Mds.25850  0.324
2014 Burn D, Weintraub D, Robbins T. Introduction: The importance of cognition in movement disorders Movement Disorders. 29: 581-583. PMID 24757107 DOI: 10.1002/Mds.25871  0.447
2014 Tolosa E, Litvan I, Höglinger GU, Burn D, Lees A, Andrés MV, Gómez-Carrillo B, León T, Del Ser T. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 470-8. PMID 24532007 DOI: 10.1002/Mds.25824  0.345
2014 Rochester L, Galna B, Lord S, Burn D. The nature of dual-task interference during gait in incident Parkinson's disease Neuroscience. 265: 83-94. PMID 24508154 DOI: 10.1016/J.Neuroscience.2014.01.041  0.379
2014 Emre M, Poewe W, De Deyn PP, Barone P, Kulisevsky J, Pourcher E, van Laar T, Storch A, Micheli F, Burn D, Durif F, Pahwa R, Callegari F, Tenenbaum N, Strohmaier C. Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study. Clinical Neuropharmacology. 37: 9-16. PMID 24434526 DOI: 10.1097/Wnf.0000000000000010  0.41
2014 Urwyler P, Nef T, Killen A, Collerton D, Thomas A, Burn D, McKeith I, Mosimann UP. Visual complaints and visual hallucinations in Parkinson's disease. Parkinsonism & Related Disorders. 20: 318-22. PMID 24405755 DOI: 10.1016/J.Parkreldis.2013.12.009  0.408
2014 Hurt CS, Alkufri F, Brown RG, Burn DJ, Hindle JV, Landau S, Wilson KC, Samuel M. Motor phenotypes, medication and mood: further associations with impulsive behaviours in Parkinson's disease. Journal of Parkinson's Disease. 4: 245-54. PMID 24366927 DOI: 10.3233/JPD-130314  0.388
2014 Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G, Chinnery PF, O'Brien JT, ... ... Burn DJ, et al. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology. 82: 308-16. PMID 24363137 DOI: 10.1212/Wnl.0000000000000066  0.404
2014 Strafella AP, Burn D. Science to practice: Imaging tools to study cognition in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 283-4. PMID 24338679 DOI: 10.1002/Mds.25769  0.395
2014 Geurtsen GJ, Hoogland J, Goldman JG, Schmand BA, Tröster AI, Burn DJ, Litvan I. Parkinson's disease mild cognitive impairment: application and validation of the criteria. Journal of Parkinson's Disease. 4: 131-7. PMID 24296865 DOI: 10.3233/Jpd-130304  0.404
2014 Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Coleman SY, Brooks DJ, Barker RA, Burn DJ. Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 195-202. PMID 24123307 DOI: 10.1002/Mds.25664  0.339
2014 Duncan GW, Khoo TK, Coleman SY, Brayne C, Yarnall AJ, O'Brien JT, Barker RA, Burn DJ. The incidence of Parkinson's disease in the North-East of England. Age and Ageing. 43: 257-63. PMID 23880142 DOI: 10.1093/Ageing/Aft091  0.386
2014 Marrinan S, Bajaj N, Barker R, Ben-Shlomo Y, Emmanuel A, Foltynie T, Grosset D, Morris H, Williams N, Wood N, Burn D. 131Gastroparesis Symptoms In Early Parkinson'S Disease Age and Ageing. 43. DOI: 10.1093/Ageing/Afu047.4  0.421
2013 Lawson RA, Millar D, Brown RG, Burn DJ. Guided self-help for the management of worry in Parkinson's disease: a pilot study. Journal of Parkinson's Disease. 3: 61-8. PMID 23938312 DOI: 10.3233/JPD-120156  0.344
2013 Jenner P, Morris HR, Robbins TW, Goedert M, Hardy J, Ben-Shlomo Y, Bolam P, Burn D, Hindle JV, Brooks D. Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. Journal of Parkinson's Disease. 3: 1-11. PMID 23938306 DOI: 10.3233/Jpd-130175  0.505
2013 Lord S, Godfrey A, Galna B, Mhiripiri D, Burn D, Rochester L. Ambulatory activity in incident Parkinson's: more than meets the eye? Journal of Neurology. 260: 2964-72. PMID 23900754 DOI: 10.1007/S00415-013-7037-5  0.452
2013 Yarnall AJ, Rochester L, Burn DJ. Mild cognitive impairment in parkinson's disease Age and Ageing. 42: 567-576. PMID 23868092 DOI: 10.1093/ageing/aft085  0.418
2013 Hudson G, Nalls M, Evans JR, Breen DP, Winder-Rhodes S, Morrison KE, Morris HR, Williams-Gray CH, Barker RA, Singleton AB, Hardy J, Wood NE, Burn DJ, Chinnery PF. Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology. 80: 2042-8. PMID 23645593 DOI: 10.1212/Wnl.0B013E318294B434  0.314
2013 Burn DJ, Barker RA. Mild cognitive impairment in Parkinson's disease: millstone or milestone? Practical Neurology. 13: 68-9. PMID 23468557 DOI: 10.1136/practneurol-2013-000539  0.326
2013 Yarnall AJ, Rochester L, Baker MR, David R, Khoo TK, Duncan GW, Galna B, Burn DJ. Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease? Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1285-8. PMID 23450646 DOI: 10.1002/mds.25360  0.391
2013 Duncan GW, Firbank MJ, O'Brien JT, Burn DJ. Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease? Movement Disorders : Official Journal of the Movement Disorder Society. 28: 425-38. PMID 23450518 DOI: 10.1002/Mds.25352  0.395
2013 Archibald NK, Hutton SB, Clarke MP, Mosimann UP, Burn DJ. Visual exploration in Parkinson's disease and Parkinson's disease dementia. Brain : a Journal of Neurology. 136: 739-50. PMID 23436502 DOI: 10.1093/brain/awt005  0.343
2013 Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 668-70. PMID 23408503 DOI: 10.1002/mds.25383  0.375
2013 Lord S, Galna B, Coleman S, Burn D, Rochester L. Mild depressive symptoms are associated with gait impairment in early Parkinson's disease Movement Disorders. 28: 634-639. PMID 23390120 DOI: 10.1002/Mds.25338  0.444
2013 Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O'Brien JT, Brooks DJ, Barker RA, Burn DJ. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 80: 276-81. PMID 23319473 DOI: 10.1212/Wnl.0B013E31827Deb74  0.39
2013 Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, Ferreira J, Gasser T, Grandas F, Kanovsky P, Kostic V, et al. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 16-34. PMID 23279440 DOI: 10.1111/Ene.12022  0.474
2013 Ferreira JJ, Katzenschlager R, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, Rascol O, et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 5-15. PMID 23279439 DOI: 10.1111/J.1468-1331.2012.03866.X  0.435
2013 Gibson G, Mottram PG, Burn DJ, Hindle JV, Landau S, Samuel M, Hurt CS, Brown RG, M Wilson KC. Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study. International Journal of Geriatric Psychiatry. 28: 626-31. PMID 22927195 DOI: 10.1002/gps.3869  0.323
2013 Grosset D, Malek N, Bajaj N, Barker R, Burn D, Ben–Shlomo Y, Foltynie T, Morris H, Williams N, Wood N. TRACKING PARKINSON'S (THE PROBAND STUDY)–INTERIM REPORT FROM THE FIRST 1000 CASES Journal of Neurology, Neurosurgery & Psychiatry. 84: e2.70-e2. DOI: 10.1136/Jnnp-2013-306573.161  0.425
2013 Malek N, Bajaj N, Barker R, Ben–Shlomo Y, Burn D, Foltynie T, Morris H, Williams N, Wood N, Grosset D. FAMILY HISTORY IN YOUNG ONSET PARKINSON'S DISEASE Journal of Neurology, Neurosurgery & Psychiatry. 84: e2.69-e2. DOI: 10.1136/Jnnp-2013-306573.160  0.397
2013 Duncan GW, Firbank MJ, Yarnall AJ, Barker RA, O'Brien JT, Burn DJ. GREY MATTER CORRELATIONS OF COGNITIVE IMPAIRMENT IN EARLY PARKINSON'S DISEASE: THE INCIDENCE OF COGNITIVE IMPAIRMENT IN COHORTS WITH LONGITUDINAL EVALUATION–PARKINSON'S DISEASE (ICICLE–PD) STUDY: Table 1 Journal of Neurology, Neurosurgery & Psychiatry. 84: e2.63-e2. DOI: 10.1136/Jnnp-2013-306573.155  0.4
2013 Duncan GW, Yarnall AJ, Firbank MJ, Barker RA, O'Brien JT, Burn DJ. GREY MATTER AND CSF AMYLOID IN EARLY NON–DEMENTED PARKINSON'S DISEASE: THE INCIDENCE OF COGNITIVE IMPAIRMENT IN COHORTS WITH LONGITUDINAL EVALUATION IN PARKINSON'S DISEASE (ICICLE–PD) STUDY: Table 1 Journal of Neurology, Neurosurgery & Psychiatry. 84: e2.62-e2. DOI: 10.1136/Jnnp-2013-306573.154  0.378
2013 Khoo T, O'Brien J, Burn D, Yarnall A, Duncan G, Barker R. The impact of motor and non-motor symptoms upon health-related quality of life in early Parkinson's disease: the incidence of cognitive impairment in cohorts with longitudinal evaluation: Parkinson's Disease (ICICLE-PD) Study Age and Ageing. DOI: 10.1093/Ageing/Aft106  0.47
2012 Rochester L, Yarnall AJ, Baker MR, David RV, Lord S, Galna B, Burn DJ. Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease. Brain : a Journal of Neurology. 135: 2779-88. PMID 22961550 DOI: 10.1093/brain/aws207  0.336
2012 Galna B, Lord S, Daud D, Archibald N, Burn D, Rochester L. Visual sampling during walking in people with Parkinson's disease and the influence of environment and dual-task Brain Research. 1473: 35-43. PMID 22824332 DOI: 10.1016/J.Brainres.2012.07.017  0.4
2012 Lord S, Archibald N, Mosimann U, Burn D, Rochester L. Dorsal rather than ventral visual pathways discriminate freezing status in Parkinson's disease Parkinsonism and Related Disorders. 18: 1094-1096. PMID 22705127 DOI: 10.1016/J.Parkreldis.2012.05.016  0.401
2012 Hurt CS, Landau S, Burn DJ, Hindle JV, Samuel M, Wilson K, Brown RG. Cognition, coping, and outcome in Parkinson's disease. International Psychogeriatrics. 24: 1656-63. PMID 22612910 DOI: 10.1017/S1041610212000749  0.311
2012 Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, Ziemssen T. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 617-26. PMID 22508280 DOI: 10.1002/mds.24996  0.402
2012 Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 349-56. PMID 22275317 DOI: 10.1002/Mds.24893  0.386
2012 Charlesworth G, Gandhi S, Bras JM, Barker RA, Burn DJ, Chinnery PF, Gentleman SM, Guerreiro R, Hardy J, Holton JL, Lees A, Morrison K, Sheerin UM, Williams N, Morris H, et al. Tau acts as an independent genetic risk factor in pathologically proven PD. Neurobiology of Aging. 33: 838.e7-11. PMID 22221882 DOI: 10.1016/J.Neurobiolaging.2011.11.001  0.356
2012 Pienaar IS, Burn D, Morris C, Dexter D. Synaptic protein alterations in Parkinson's disease. Molecular Neurobiology. 45: 126-43. PMID 22205299 DOI: 10.1007/S12035-011-8226-9  0.376
2012 Pienaar IS, Morris C, Burn D, Racca C, Nelson G, Turnbull D. 1.128 Differential Mitochondrial Protein Expression Within Single Glycinergic Neurons Of The Pedunculopontine Nucleus Of Parkinson'S Disease Patients Parkinsonism & Related Disorders. 18. DOI: 10.1016/S1353-8020(11)70242-5  0.34
2011 Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D. Cognitive impairment in nondemented Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2483-95. PMID 22170275 DOI: 10.1002/Mds.23919  0.474
2011 Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2387-95. PMID 21953737 DOI: 10.1002/mds.23891  0.378
2011 Yarnall A, Rochester L, Burn DJ. The interplay of cholinergic function, attention, and falls in Parkinson's disease Movement Disorders. 26: 2496-2503. PMID 21898597 DOI: 10.1002/mds.23932  0.41
2011 Hudson G, Faini D, Stutt A, Eccles M, Robinson L, Burn DJ, Chinnery PF. No evidence of substantia nigra telomere shortening in Parkinson's disease. Neurobiology of Aging. 32: 2107.e3-5. PMID 21794951 DOI: 10.1016/j.neurobiolaging.2011.05.022  0.35
2011 Weintraub D, Burn DJ. Parkinson's disease: the quintessential neuropsychiatric disorder. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1022-31. PMID 21626547 DOI: 10.1002/mds.23664  0.306
2011 Rochester L, Baker K, Nieuwboer A, Burn D. Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: Selective responses to internal and external cues Movement Disorders. 26: 430-435. PMID 21462258 DOI: 10.1002/Mds.23450  0.345
2011 Lord S, Baker K, Nieuwboer A, Burn D, Rochester L. Gait variability in Parkinson's disease: An indicator of non-dopaminergic contributors to gait dysfunction? Journal of Neurology. 258: 566-572. PMID 21052710 DOI: 10.1007/S00415-010-5789-8  0.38
2011 Spencer CC, Plagnol V, Strange A, Gardner M, Paisan-Ruiz C, Band G, Barker RA, Bellenguez C, Bhatia K, Blackburn H, Blackwell JM, Bramon E, Brown MA, ... ... Burn D, et al. Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Human Molecular Genetics. 20: 345-53. PMID 21044948 DOI: 10.1093/Hmg/Ddq469  0.348
2011 Hurt CS, Thomas BA, Burn DJ, Hindle JV, Landau S, Samuel M, Wilson KC, Brown RG. Coping in Parkinson's disease: an examination of the coping inventory for stressful situations. International Journal of Geriatric Psychiatry. 26: 1030-7. PMID 20872797 DOI: 10.1002/gps.2634  0.358
2011 Burn DJ. The treatment of cognitive impairment associated with Parkinson's disease. Brain Pathology (Zurich, Switzerland). 20: 672-8. PMID 20522093 DOI: 10.1111/j.1750-3639.2009.00367.x  0.389
2010 Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology. 75: 1062-9. PMID 20855849 DOI: 10.1212/Wnl.0B013E3181F39D0E  0.466
2010 Chastin SFM, Baker K, Jones D, Burn D, Granat MH, Rochester L. The pattern of habitual sedentary behavior is different in advanced Parkinson's disease Movement Disorders. 25: 2114-2120. PMID 20721926 DOI: 10.1002/Mds.23146  0.47
2010 Gallagher P, Archibald N, Goldsmith P, Burn D. Two in the hand, an essential lesson in tremor management. Practical Neurology. 10: 160-163. PMID 20498189 DOI: 10.1136/Jnnp.2010.211847  0.303
2010 Hudson G, Stutt A, Eccles M, Robinson L, Allcock LM, Wesnes KA, Chinnery PF, Burn DJ. Genetic variation of CHRNA4 does not modulate attention in Parkinson's disease. Neuroscience Letters. 479: 123-5. PMID 20493238 DOI: 10.1016/j.neulet.2010.05.041  0.33
2010 Docherty MJ, Burn DJ. Parkinson's disease dementia. Current Neurology and Neuroscience Reports. 10: 292-8. PMID 20428976 DOI: 10.1007/s11910-010-0113-7  0.337
2010 Silveira-Moriyama L, Hughes G, Church A, Ayling H, Williams DR, Petrie A, Holton J, Revesz T, Kingsbury A, Morris HR, Burn DJ, Lees AJ. Hyposmia in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 570-7. PMID 20209627 DOI: 10.1002/mds.22688  0.354
2010 Vasudev A, Palmer T, Thomas A, Burn D, Barker W. Factors predicting discharge of Huntington's disease patients from a neuropsychiatry unit. International Psychogeriatrics / Ipa. 22: 489-92. PMID 20085671 DOI: 10.1017/S1041610209991621  0.334
2010 Khoo TK, Burn DJ. Non-motor symptoms may herald Parkinson's disease. The Practitioner. 253: 19-24, 2. PMID 19873855  0.358
2010 Massey L, Paviour D, Fox N, Micallef C, Burn D, Holton J, Lees A, Jager H, Revesz T, O'Sullivan S. Blinded Analysis Of Conventional Mri In A Cohort Of Pathologically Confirmed Parkinsonian Illnesses Journal of Neurology, Neurosurgery, and Psychiatry. 81. DOI: 10.1136/Jnnp.2010.226340.161  0.447
2010 Oertel WH, Berardelli A, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Ferreira JJ, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, et al. Late (Complicated) Parkinson's Disease European Handbook of Neurological Management: Second Edition. 1: 237-267. DOI: 10.1002/9781444328394.ch15  0.348
2010 Oertel WH, Berardelli A, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Ferreira JJ, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, et al. Early (Uncomplicated) Parkinson's Disease European Handbook of Neurological Management: Second Edition. 1: 217-236. DOI: 10.1002/9781444328394.ch14  0.358
2009 Elstner M, Morris CM, Heim K, Lichtner P, Bender A, Mehta D, Schulte C, Sharma M, Hudson G, Goldwurm S, Giovanetti A, Zeviani M, Burn DJ, McKeith IG, Perry RH, et al. Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene. Annals of Neurology. 66: 792-8. PMID 20035503 DOI: 10.1002/Ana.21780  0.315
2009 Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, Burn DJ, Caparros-Lefebvre D, Frey KA, de Yebenes JG, Gasser T, Heutink P, Höglinger G, Jamrozik Z, Jellinger KA, Kazantsev A, et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 297-309. PMID 19364361 DOI: 10.1111/J.1468-1331.2008.02513.X  0.36
2009 Hudson G, Tiangyou W, Stutt A, Eccles M, Robinson L, Burn DJ, Chinnery PF. No association between common POLG1 variants and sporadic idiopathic Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1092-4. PMID 19243043 DOI: 10.1002/mds.22310  0.333
2009 Rochester L, Burn DJ, Woods G, Godwin J, Nieuwboer A. Does auditory rhythmical cueing improve gait in people with Parkinson's disease and cognitive impairment? A feasibility study. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 839-45. PMID 19199354 DOI: 10.1002/mds.22400  0.333
2009 Marshall VL, Reininger CB, Marquardt M, Patterson J, Hadley DM, Oertel WH, Benamer HT, Kemp P, Burn D, Tolosa E, Kulisevsky J, Cunha L, Costa D, Booij J, Tatsch K, et al. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 500-8. PMID 19117369 DOI: 10.1002/Mds.22108  0.447
2009 Miller N, Allcock L, Hildreth A, Jones D, Noble E, Burn D. Swallowing problems in Parkinson disease: frequency and clinical correlates Journal of Neurology, Neurosurgery, and Psychiatry. 80: 1047-1049. PMID 19028764 DOI: 10.1136/Jnnp.2008.157701  0.489
2009 Allcock LM, Rowan EN, Steen IN, Wesnes K, Kenny RA, Burn DJ. Impaired attention predicts falling in Parkinson's disease. Parkinsonism & Related Disorders. 15: 110-5. PMID 18487069 DOI: 10.1016/j.parkreldis.2008.03.010  0.385
2009 Whitehead D, Simpson A, Hurt C, Burn D, Hindle J, Landau S, Samuel M, Wilson K, Brown RG. P1.185 Worry in Parkinson's disease: baseline data from the PROMS-PD cohort Parkinsonism & Related Disorders. 15. DOI: 10.1016/S1353-8020(09)70307-4  0.491
2009 Hurt C, Thomas B, Burn D, Hindle J, Landau S, Samuel M, Wilson K, Brown R. P1.138 Coping in Parkinson's disease: an examination of the coping inventory for stressful situations Parkinsonism & Related Disorders. 15. DOI: 10.1016/S1353-8020(09)70260-3  0.373
2009 Brown R, Hurt C, Burn D, Hindle J, Landau S, Samuel M, Wilson K. P1.042 A prospective study of mood states in Parkinson's disease (PROMS-PD) Parkinsonism & Related Disorders. 15. DOI: 10.1016/S1353-8020(09)70164-6  0.482
2009 Whitehead D, Simpson A, Hurt C, Burn D, Hindle J, Landau S, Samuel M, Wilson K, Brown RG. P1.026 Cognitive proflle and mild cognitive impairment (MCI) in Parkinson's disease: baseline data from the PROMS-PD cohort Parkinsonism & Related Disorders. 15. DOI: 10.1016/S1353-8020(09)70148-8  0.456
2008 Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, ... ... Burn DJ, et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. Bmc Medicine. 6: 32. PMID 18986508 DOI: 10.1186/1741-7015-6-32  0.302
2008 McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, ... ... Burn DJ, et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1596-601. PMID 18649400 DOI: 10.1002/Mds.22186  0.351
2008 DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, ... ... Burn DJ, et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Human Genetics. 124: 95-9. PMID 18587682 DOI: 10.1007/S00439-008-0526-4  0.311
2008 Taylor JP, Rowan EN, Lett D, O'Brien JT, McKeith IG, Burn DJ. Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 1318-23. PMID 18586866 DOI: 10.1136/Jnnp.2008.147629  0.322
2008 Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, ... ... Burn DJ, et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 71: 28-34. PMID 18509094 DOI: 10.1212/01.Wnl.0000304051.01650.23  0.335
2008 Lord S, Rochester L, Hetherington V, Allcock LM, Burn D. P1.088 The role of cognitive and motor characteristics during single, dual and multi-task gait performance in Parkinson's disease (PD) Parkinsonism & Related Disorders. 14. DOI: 10.1016/S1353-8020(08)70185-8  0.461
2007 Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2314-24. PMID 18098298 DOI: 10.1002/Mds.21844  0.449
2007 Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJ, Brown J, Ban M, Spillantini MG, Compston A, Burn DJ, Chinnery PF, Barker RA, Sawcer SJ. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Annals of Neurology. 62: 145-53. PMID 17683088 DOI: 10.1002/Ana.21192  0.412
2007 Burn DJ. Sex and Parkinson's disease: a world of difference? Journal of Neurology, Neurosurgery, and Psychiatry. 78: 787. PMID 17635975 DOI: 10.1136/JNNP.2006.109991  0.328
2007 Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1689-707; quiz 1837. PMID 17542011 DOI: 10.1002/Mds.21507  0.392
2007 Miller N, Allcock L, Jones D, Noble E, Hildreth AJ, Burn DJ. Prevalence and pattern of perceived intelligibility changes in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 1188-90. PMID 17400592 DOI: 10.1136/jnnp.2006.110171  0.352
2007 Rowan E, McKeith IG, Saxby BK, O'Brien JT, Burn D, Mosimann U, Newby J, Daniel S, Sanders J, Wesnes K. Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders. 23: 161-7. PMID 17192712 DOI: 10.1159/000098335  0.42
2007 Burn DJ. Cortical Lewy body disease and Parkinson's disease dementia. Current Opinion in Neurology. 19: 572-9. PMID 17102696 DOI: 10.1097/01.wco.0000247607.34697.a2  0.36
2007 Grosset D, Taurah L, Burn DJ, MacMahon D, Forbes A, Turner K, Bowron A, Walker R, Findley L, Foster O, Patel K, Clough C, Castleton B, Smith S, Carey G, et al. A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 465-9. PMID 17098846 DOI: 10.1136/jnnp.2006.098327  0.335
2007 Boddy F, Rowan EN, Lett D, O'Brien JT, McKeith IG, Burn DJ. Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry. 22: 529-35. PMID 17096456 DOI: 10.1002/Gps.1709  0.346
2007 Allcock LM, Kenny RA, Burn DJ. Clinical phenotype of subjects with Parkinson's disease and orthostatic hypotension: autonomic symptom and demographic comparison. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1851-5. PMID 16958096 DOI: 10.1002/mds.20996  0.36
2006 Gauthier S, Vellas B, Farlow M, Burn D. Aggressive course of disease in dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 210-7. PMID 19595889 DOI: 10.1016/J.Jalz.2006.03.002  0.397
2006 Miller N, Noble E, Jones D, Burn D. Hard to swallow: dysphagia in Parkinson’s disease Age and Ageing. 35: 614-618. PMID 17047007 DOI: 10.1093/Ageing/Afl105  0.385
2006 Burton EJ, McKeith IG, Burn DJ, Firbank MJ, O'Brien JT. Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 842-9. PMID 17001024 DOI: 10.1097/01.Jgp.0000236596.56982.1C  0.302
2006 Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu C, Lane R. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1899-907. PMID 16960863 DOI: 10.1002/Mds.21077  0.358
2006 Tiangyou W, Hudson G, Ghezzi D, Ferrari G, Zeviani M, Burn DJ, Chinnery PF. POLG1 in idiopathic Parkinson disease. Neurology. 67: 1698-700. PMID 16943369 DOI: 10.1212/01.wnl.0000238963.07425.d5  0.37
2006 Allcock LM, Kenny RA, Mosimann UP, Tordoff S, Wesnes KA, Hildreth AJ, Burn DJ. Orthostatic hypotension in Parkinson's disease: Association with cognitive decline? International Journal of Geriatric Psychiatry. 21: 778-783. PMID 16906622 DOI: 10.1002/gps.1562  0.362
2006 McKeith IG, Rowan E, Askew K, Naidu A, Allan L, Barnett N, Lett D, Mosimann UP, Burn D, O'Brien JT. More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 582-8. PMID 16816011 DOI: 10.1097/01.Jgp.0000216177.08010.F4  0.374
2006 Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 585-9. PMID 16614017 DOI: 10.1136/Jnnp.2005.081711  0.497
2006 Miller N, Noble E, Jones D, Burn D. Life with communication changes in Parkinson’s disease Age and Ageing. 35: 235-239. PMID 16540492 DOI: 10.1093/Ageing/Afj053  0.374
2006 Marsh L, McDonald WM, Cummings J, Ravina B, Abraham N, Babcock DJ, Black KJ, Burn D, Como P, Edwards E, Elliott R, Friedman J, Gwinn-Hardy K, Hamer RM, Kelley M, et al. Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group Movement Disorders. 21: 148-158. PMID 16211591 DOI: 10.1002/Mds.20723  0.443
2006 Millar D, Griffiths P, Zermansky AJ, Burn DJ. Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 199-207. PMID 16200534 DOI: 10.1002/Mds.20707  0.317
2006 Burn DJ. Update on dementia with Lewy bodies. Current Neurology and Neuroscience Reports. 5: 339-44. PMID 16131416 DOI: 10.1007/S11910-005-0057-5  0.343
2006 Noble E, Jones D, Miller N, Burn D. Speech and Language therapy provision for people with Parkinson's disease International Journal of Therapy and Rehabilitation. 13: 323-327. DOI: 10.12968/Ijtr.2006.13.7.21409  0.44
2006 Hughes G, Burn D. Diagnosis and management of Parkinson's disease Prescriber. 17: 56-63. DOI: 10.1002/Psb.439  0.414
2005 Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, ... ... Burn DJ, et al. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology. 65: 1823-5. PMID 16344533 DOI: 10.1212/01.Wnl.0000187075.81589.Fd  0.314
2005 McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65: 1863-72. PMID 16237129 DOI: 10.1212/01.Wnl.0000187889.17253.B1  0.305
2005 Allan LM, Ballard CG, Burn DJ, Kenny RA. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. Journal of the American Geriatrics Society. 53: 1681-7. PMID 16181166 DOI: 10.1111/J.1532-5415.2005.53552.X  0.326
2005 Firbank MJ, Molloy S, McKeith IG, Burn DJ, O'Brien JT. Longitudinal change in 99mTcHMPAO cerebral perfusion SPECT in Parkinson's disease over one year. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1448-51. PMID 16170094 DOI: 10.1136/Jnnp.2004.058685  0.377
2005 Thomas AJ, Burn DJ, Rowan EN, Littlewood E, Newby J, Cousins D, Pakrasi S, Richardson J, Sanders J, McKeith IG. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies. International Journal of Geriatric Psychiatry. 20: 938-44. PMID 16163744 DOI: 10.1002/Gps.1381  0.357
2005 Burton EJ, McKeith IG, Burn DJ, O'Brien JT. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1571-6. PMID 16116613 DOI: 10.1002/Mds.20652  0.355
2005 Molloy S, McKeith IG, O'Brien JT, Burn DJ. The role of levodopa in the management of dementia with Lewy bodies. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1200-3. PMID 16107351 DOI: 10.1136/Jnnp.2004.052332  0.339
2005 Firbank MJ, Burn DJ, McKeith IG, O'Brien JT. Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies. International Journal of Geriatric Psychiatry. 20: 776-82. PMID 16035122 DOI: 10.1002/Gps.1359  0.355
2005 O'Brien JT, Firbank MJ, Mosimann UP, Burn DJ, McKeith IG. Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Research. 139: 79-88. PMID 15964748 DOI: 10.1016/J.Pscychresns.2005.04.002  0.311
2005 Colloby SJ, Williams ED, Burn DJ, Lloyd JJ, McKeith IG, O'Brien JT. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT. European Journal of Nuclear Medicine and Molecular Imaging. 32: 1176-85. PMID 15931516 DOI: 10.1007/S00259-005-1830-Z  0.421
2005 Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. The Journal of Clinical Psychiatry. 66: 633-7. PMID 15889951  0.439
2005 Pyle A, Foltynie T, Tiangyou W, Lambert C, Keers SM, Allcock LM, Davison J, Lewis SJ, Perry RH, Barker R, Burn DJ, Chinnery PF. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Annals of Neurology. 57: 564-7. PMID 15786469 DOI: 10.1002/Ana.20417  0.33
2005 Mosimann UP, Müri RM, Burn DJ, Felblinger J, O'Brien JT, McKeith IG. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Brain : a Journal of Neurology. 128: 1267-76. PMID 15774501 DOI: 10.1093/Brain/Awh484  0.335
2005 Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology. 64: 861-5. PMID 15753423 DOI: 10.1212/01.Wnl.0000153070.82309.D4  0.407
2005 Warren NM, Piggott MA, Perry EK, Burn DJ. Cholinergic systems in progressive supranuclear palsy. Brain : a Journal of Neurology. 128: 239-49. PMID 15649952 DOI: 10.1093/Brain/Awh391  0.331
2005 Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. The Journal of Clinical Psychiatry. 66: 633-637. DOI: 10.4088/Jcp.V66N0514  0.541
2004 Mosimann UP, Mather G, Wesnes KA, O'Brien JT, Burn DJ, McKeith IG. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology. 63: 2091-6. PMID 15596755 DOI: 10.1212/01.Wnl.0000145764.70698.4E  0.336
2004 Colloby SJ, O'Brien JT, Fenwick JD, Firbank MJ, Burn DJ, McKeith IG, Williams ED. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. Neuroimage. 23: 956-66. PMID 15528096 DOI: 10.1016/J.Neuroimage.2004.06.045  0.357
2004 Allcock LM, Ullyart K, Kenny RA, Burn DJ. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1470-1. PMID 15377699 DOI: 10.1136/JNNP.2003.029413  0.359
2004 Johnson J, Hague SM, Hanson M, Gibson A, Wilson KE, Evans EW, Singleton AA, McInerney-Leo A, Nussbaum RL, Hernandez DG, Gallardo M, McKeith IG, Burn DJ, Ryu M, Hellstrom O, et al. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology. 63: 554-6. PMID 15304594 DOI: 10.1212/01.Wnl.0000133401.09043.44  0.418
2004 O'Brien JT, Colloby S, Fenwick J, Williams ED, Firbank M, Burn D, Aarsland D, McKeith IG. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Archives of Neurology. 61: 919-25. PMID 15210531 DOI: 10.1001/Archneur.61.6.919  0.471
2004 Stewart D, Morgan E, Burn D, Grosset D, Chaudhuri KR, MacMahon D, Needleman F, Macphee G, Heywood P. Dopamine agonist switching in Parkinson's disease. Hospital Medicine (London, England : 1998). 65: 215-9. PMID 15127675 DOI: 10.12968/Hosp.2004.65.4.12734  0.38
2004 Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain : a Journal of Neurology. 127: 791-800. PMID 14749292 DOI: 10.1093/Brain/Awh088  0.381
2004 McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, et al. Dementia with Lewy bodies. The Lancet. Neurology. 3: 19-28. PMID 14693108 DOI: 10.1016/S1474-4422(03)00619-7  0.33
2004 Burton EJ, McKeith IG, Burn DJ, Williams D, O'Brien JT. P2-236 A voxel-based study of Parkinson's disease with and without dementia Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80982-5  0.361
2004 O'Brien JT, Colloby S, Pakrasi S, Burn D, Williams D, Wyper D, Owens J, McKeith I. P2-147 123I-QNB spect demonstrates loss of cholinergic muscarinic receptors in Alzheimer's disease, but occipital increases in dementia with Lewy bodies and Parkinson's disease dementia Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80894-7  0.375
2003 Cousins DA, Burton EJ, Burn D, Gholkar A, McKeith IG, O'Brien JT. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study. Neurology. 61: 1191-5. PMID 14610119 DOI: 10.1212/01.Wnl.0000091889.20347.30  0.394
2003 Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage. 20: 1309-19. PMID 14568499 DOI: 10.1016/S1053-8119(03)00364-1  0.37
2003 Collerton D, Burn D, McKeith I, O’Brien J. Systematic Review and Meta-Analysis Show that Dementia with Lewy Bodies Is a Visual-Perceptual and Attentional-Executive Dementia Dementia and Geriatric Cognitive Disorders. 16: 229-237. PMID 14512718 DOI: 10.1159/000072807  0.448
2003 Burn DJ, McKeith IG. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: S72-9. PMID 14502659 DOI: 10.1002/Mds.10566  0.414
2003 Burn DJ, Rowan EN, Minett T, Sanders J, Myint P, Richardson J, Thomas A, Newby J, Reid J, O'Brien JT, McKeith IG. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 884-9. PMID 12889077 DOI: 10.1002/Mds.10455  0.395
2003 Almeida OP, Burton EJ, McKeith I, Gholkar A, Burn D, O'Brien JT. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 16: 57-63. PMID 12784028 DOI: 10.1159/000070676  0.504
2003 Cairns NJ, Perry RH, Jaros E, Burn D, McKeith IG, Lowe JS, Holton J, Rossor MN, Skullerud K, Duyckaerts C, Cruz-Sanchez FF, Lantos PL. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neuroscience Letters. 341: 177-80. PMID 12697277 DOI: 10.1016/S0304-3940(03)00100-9  0.366
2003 Su Y, Allen CR, Geng D, Burn D, Brechany U, Bell GD, Rowland R. 3-D motion system ("data-gloves"): application for Parkinson's disease Ieee Transactions On Instrumentation and Measurement. 52: 662-674. DOI: 10.1109/Tim.2003.814702  0.386
2003 Colloby SJ, Fenwick JD, Williams ED, Burn DJ, McKeith IG, OʼBrien JT. 3. Striatal uptake of 123I-FPCIT in dementia with Lewy bodies, Alzheimerʼs disease and Parkinsonʼs disease Nuclear Medicine Communications. 24: 444-445. DOI: 10.1097/00006231-200304000-00022  0.304
2002 Ballard CG, Aarsland D, McKeith I, O'Brien J, Gray A, Cormack F, Burn D, Cassidy T, Starfeldt R, Larsen JP, Brown R, Tovee M. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology. 59: 1714-20. PMID 12473758 DOI: 10.1212/01.Wnl.0000036908.39696.Fd  0.474
2002 Burn D. Depression in Parkinson's disease European Journal of Neurology. 9: 44-54. PMID 12464121 DOI: 10.1046/J.1468-1331.9.S3.6.X  0.387
2001 Morris HR, Schrag A, Nath U, Burn D, Quinn NP, Daniel S, Wood NW, Lees AJ. Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy Neuroscience Letters. 312: 118-120. PMID 11595348 DOI: 10.1016/S0304-3940(01)02190-5  0.346
2000 Ballard C, O'Brien J, Swann A, Neill D, Lantos P, Holmes C, Burn D, Ince P, Perry R, McKeith I. One year follow-up of parkinsonism in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders. 11: 219-22. PMID 10867448 DOI: 10.1159/000017240  0.425
2000 Thomas NJ, Morris CM, Scaravilli F, Johansson J, Rossor M, De Lange R, St Clair D, Nicoll J, Blank C, Coulthard A, Bushby K, Ince PG, Burn D, Kalaria RN. Hereditary vascular dementia linked to notch 3 mutations. CADASIL in British families. Annals of the New York Academy of Sciences. 903: 293-8. PMID 10818518 DOI: 10.1111/J.1749-6632.2000.Tb06379.X  0.316
2000 Nath U, Burn D. The epidemiology of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Parkinsonism & Related Disorders. 6: 145-153. PMID 10817953 DOI: 10.1016/S1353-8020(00)00011-0  0.321
2000 McAuley DF, Johnston GD, Marra C, Silveri MC, Gainotti G, Ólafsdóttir M, Skoog I, Marcusson J, Armstrong RA, Cairns NJ, Lantos PL, McGleenon BM, Passmore AP, Eckert GP, Maras A, ... ... Burn D, et al. APOE Genotype and Alzheimer´s Disease Dementia and Geriatric Cognitive Disorders. 11: 237-237. DOI: 10.1159/000017243  0.33
1999 Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain : a Journal of Neurology. 122: 1449-68. PMID 10430831 DOI: 10.1093/Brain/122.8.1449  0.447
1999 Piccini P, Burn DJ, Ceravolo R, Maraganore D, Brooks DJ. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Annals of Neurology. 45: 577-82. PMID 10319879 DOI: 10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O  0.397
1997 Ballard C, McKeith I, Burn D, Harrison R, O'Brien J, Lowery K, Campbell M, Perry R, Ince P. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurologica Scandinavica. 96: 366-71. PMID 9449473 DOI: 10.1111/J.1600-0404.1997.Tb00299.X  0.447
1997 Zeidler M, Stewart GE, Barraclough CR, Bateman DE, Bates D, Burn DJ, Colchester AC, Durward W, Fletcher NA, Hawkins SA, Mackenzie JM, Will RG. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet. 350: 903-7. PMID 9314867 DOI: 10.1016/S0140-6736(97)07472-2  0.318
1997 Piccini P, Morrish PK, Turjanski N, Sawle GV, Burn DJ, Weeks RA, Mark MH, Maraganore DM, Lees AJ, Brooks DJ. Dopaminergic function in familial Parkinson's disease: A clinical and 18F‐dopa positron emission tomography study Annals of Neurology. 41: 222-229. PMID 9029071 DOI: 10.1002/Ana.410410213  0.389
1995 Menza MA, Mark MH, Burn DJ, Brooks DJ. Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 7: 176-9. PMID 7626960 DOI: 10.1176/JNP.7.2.176  0.318
1994 Burn DJ, Sawle GV, Brooks DJ. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 278-284. PMID 8158173 DOI: 10.1136/Jnnp.57.3.278  0.322
1993 Turjanski N, Bhatia K, Burn DJ, Sawle GV, Marsden CD, Brooks DJ. Comparison of striatal 18F‐dopa uptake in adult‐onset dystonia‐parkinsonism, Parkinson's disease, and dopa‐responsive dystonia Neurology. 43: 1563-1563. PMID 8351012 DOI: 10.1212/Wnl.43.8.1563  0.31
1992 Burn DJ, Mark MH, Playford ED, Maraganore DM, Zimmerman TR, Duvoisin RC, Harding AE, Marsden CD, Brooks DJ. Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology. 42: 1894-900. PMID 1407569 DOI: 10.1212/Wnl.42.10.1894  0.31
Show low-probability matches.